Tautachrome Inc (TTCM)

[canestsal]

No one cares about the revenues. They are sitting on a multi-billion dollar asset. That asset can be leveraged into multiple revenue streams and partnerships. Let me repeat, no one here is investing in TTCM because they are expecting strong revenues from existing operations. We’re here for that patent.